These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22322337)

  • 41. The path to a successful vaccine adjuvant--'the long and winding road'.
    O'Hagan DT; De Gregorio E
    Drug Discov Today; 2009 Jun; 14(11-12):541-51. PubMed ID: 19508916
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nucleic acid vaccination strategies against infectious diseases.
    Marć MA; Domínguez-Álvarez E; Gamazo C
    Expert Opin Drug Deliv; 2015; 12(12):1851-65. PubMed ID: 26365499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improving vaccine delivery using novel adjuvant systems.
    Pichichero ME
    Hum Vaccin; 2008; 4(4):262-70. PubMed ID: 18398303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 11th Annual Conference on Vaccine Research.
    O'Brien J
    Expert Rev Vaccines; 2008 Aug; 7(6):721-3. PubMed ID: 18665770
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mucosal immunisation: adjuvants and delivery systems.
    Moyle PM; McGeary RP; Blanchfield JT; Toth I
    Curr Drug Deliv; 2004 Oct; 1(4):385-96. PubMed ID: 16305400
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Delivery systems and adjuvants for oral vaccines.
    Lavelle EC; O'Hagan DT
    Expert Opin Drug Deliv; 2006 Nov; 3(6):747-62. PubMed ID: 17076597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Scientific challenges and opportunities in developing novel vaccines for the emerging and developing markets: New Technologies in Emerging Markets, October 16th-18th 2012, World Vaccine Congress, Lyon.
    Kochhar S
    Hum Vaccin Immunother; 2013 Apr; 9(4):928-31. PubMed ID: 23322007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Will Systems Biology Deliver Its Promise and Contribute to the Development of New or Improved Vaccines? From Data to Understanding through Systems Biology.
    Hagan T; Pulendran B
    Cold Spring Harb Perspect Biol; 2018 Aug; 10(8):. PubMed ID: 29038113
    [TBL] [Abstract][Full Text] [Related]  

  • 49. European strategy for vaccine development against infectious diseases.
    Matthiessen L; Lång H; Klimathianaki M; Hanrahan F; Kerstiëns B; Martini A; Draghia-Akli R
    Vaccine; 2017 Jan; 35 Suppl 1():A20-A23. PubMed ID: 28017443
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaccine adjuvants: is the pipeline clogged?
    Leitner WW
    Immunotherapy; 2012 Jun; 4(6):565-7. PubMed ID: 22788122
    [No Abstract]   [Full Text] [Related]  

  • 51. Introduction to the supplement.
    Rappuoli R
    Vaccine; 2015 Jun; 33 Suppl 2():B1-2. PubMed ID: 26022560
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Adjuvants in modern medicine and veterinary].
    Kozlov VG; Ozherelkov SV; Sanin AV; Kozhevnikova TN
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (1):91-101; discussion 101-2. PubMed ID: 24738302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vaccine innovations for emerging infectious diseases-a symposium report.
    Cable J; Srikantiah P; Crowe JE; Pulendran B; Hill A; Ginsberg A; Koff W; Mathew A; Ng T; Jansen K; Glenn G; Permar S; Wilson I; Weiner DB; Weissman D; Rappuoli R
    Ann N Y Acad Sci; 2020 Feb; 1462(1):14-26. PubMed ID: 31659752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 8th vaccine renaissance: A creative nexus for vaccine developers.
    Johnson H; Moise L; Menge A; Beseme S; De Groot AS
    Hum Vaccin Immunother; 2015; 11(9):2294-5. PubMed ID: 26158225
    [No Abstract]   [Full Text] [Related]  

  • 55. ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases.
    Baz Morelli A; Becher D; Koernig S; Silva A; Drane D; Maraskovsky E
    J Med Microbiol; 2012 Jul; 61(Pt 7):935-943. PubMed ID: 22442293
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Progress, challenges and opportunities in fish vaccine development.
    Adams A
    Fish Shellfish Immunol; 2019 Jul; 90():210-214. PubMed ID: 31039441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaccine adjuvants: smart components to boost the immune system.
    Bastola R; Noh G; Keum T; Bashyal S; Seo JE; Choi J; Oh Y; Cho Y; Lee S
    Arch Pharm Res; 2017 Nov; 40(11):1238-1248. PubMed ID: 29027637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Adjuvants--essential components of new generation vaccines].
    Dzierzbicka K; Kołodziejczyk AM
    Postepy Biochem; 2006; 52(2):204-11. PubMed ID: 17078510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multivalent minigene vaccines against infectious disease.
    An LL; Whitton JL
    Curr Opin Mol Ther; 1999 Feb; 1(1):16-21. PubMed ID: 11249678
    [No Abstract]   [Full Text] [Related]  

  • 60. Chitosan-based systems for the delivery of vaccine antigens.
    Arca HC; Günbeyaz M; Senel S
    Expert Rev Vaccines; 2009 Jul; 8(7):937-53. PubMed ID: 19538118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.